甲福明通过降低Nrf2水平来增强胃癌对西斯普拉丁的化学敏感性
Guihua Duan1, Min Qi2, Linting Xun1
1Department of Gastroenterology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.
Analytical cellular pathology (Amsterdam)
|April 23, 2025
概括
甲福明通过抑制代谢重编程和激活氧化应激来增强胃癌对西斯丁的敏感性. 这种效应由p53和AMPK通路介导,抵消核因素红色素2相关因子2 (Nrf2) 的活性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生化学
背景情况:
- 西斯普拉丁耐药性限制了胃癌治疗的有效性.
- 甲胺显示出潜在的抗癌性质.
- 了解甲胺在胃癌化学敏感性中的作用至关重要.
研究的目的:
- 为了研究甲福明对胃癌化学敏感性对西斯的作用.
- 阐明这种相互作用背后的分子机制.
- 分析甲福明对细胞活力,细胞亡,新陈代谢和氧化应激的影响.
主要方法:
- 胃癌细胞系 (NCI-N87,SNU-16) 用甲胺和西斯丁治疗.
- 检测细胞活力,细胞亡,氧化应激标记物 (氨酸,超氧化脱酶,活性氧物种),葡萄糖吸收和乳酸盐生产.
- 分析蛋白质水平和异种移植瘤的形成.
- 用于Ki67.7的免疫组织化学染色.
- 研究了核因素红色素2相关因子2 (Nrf2),p53和AMP激活蛋白激酶 (AMPK) 途径的作用.
主要成果:
- 甲胺通过降低活力,改变代谢重编程,促进细胞亡和增加氧化应激,增加了胃癌细胞中的西斯丁敏感性.
- 过度表达Nrf2逆转了甲胺的有益作用.
- 甲胺激活了p53和AMPK通路,这些通路被Nrf2上调抑制.
- 抑制AMPK或p53逆转了甲福明对思丁敏感性的增强.
结论:
- 甲胺显著增强胃癌对西斯的化学敏感性.
- 这种效果是通过抑制Nrf2表达和代谢重编程,同时激活氧化应激和p53/AMPK通路来实现的.
相关概念视频
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
136
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
136
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
134
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
134
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
146
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
146
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
02:38Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K